Advanced

Clinical Indications, Utilization, and Funding of Bariatric Surgery in Europe

Borisenko, Oleg; Colpan, Zeynep; Dillemans, Bruno; Funch-Jensen, Peter; Hedenbro, Jan LU and Ahmed, Ahmed R. (2015) In Obesity Surgery 25(8). p.1408-1416
Abstract
The objective of this study was to evaluate the current utilization, the level of endorsement by professional societies, and health technology assessment bodies, as well as the reimbursement levels for bariatric surgery in European countries. We performed an analysis of the indications for bariatric surgery based on national clinical and commissioning guidelines, current utilization of surgery, characteristics of patients who underwent surgery, and reimbursement tariffs in Belgium, Denmark, England, France, Germany, Italy, and Sweden. Data were obtained from national patient registries, administrative databases, and published literature for the year 2012. Despite clear consensus outlined in clinical guidelines, significant differences were... (More)
The objective of this study was to evaluate the current utilization, the level of endorsement by professional societies, and health technology assessment bodies, as well as the reimbursement levels for bariatric surgery in European countries. We performed an analysis of the indications for bariatric surgery based on national clinical and commissioning guidelines, current utilization of surgery, characteristics of patients who underwent surgery, and reimbursement tariffs in Belgium, Denmark, England, France, Germany, Italy, and Sweden. Data were obtained from national patient registries, administrative databases, and published literature for the year 2012. Despite clear consensus outlined in clinical guidelines, significant differences were found in the eligibility criteria for surgery. Patients with no significant comorbidities were deemed eligible if they had a body mass index (BMI) of 40 or 50 kg/m(2) in Denmark. Irrespective of the country, patients with comorbidities were eligible if they had a BMI of 35 kg/m(2). The highest utilization of bariatric surgery (number of surgeries per 1 M population) was observed in Belgium (928), Sweden (761), and France (571) while Italy (128), England (117), and Germany (72) had the lowest utilization. There was a strong negative correlation between utilization and average BMI level of the patient population (r = -.909, p = 0.005). The annual per capita spending on surgery differed significantly between countries, ranging from a,not sign0.54 in Germany to a,not sign4.33 in Belgium. There are significant variations in the clinical indications, utilization, and funding of bariatric surgery in European countries. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Bariatric surgery, Clinical indication, Reimbursement, Utilization, Health care policy
in
Obesity Surgery
volume
25
issue
8
pages
1408 - 1416
publisher
Springer
external identifiers
  • wos:000358166600154
  • scopus:84939417955
ISSN
1708-0428
DOI
10.1007/s11695-014-1537-y
language
English
LU publication?
yes
id
824bad44-c952-46f8-adc1-f8a362260fb7 (old id 7773708)
date added to LUP
2015-09-01 16:08:58
date last changed
2017-08-13 03:53:56
@article{824bad44-c952-46f8-adc1-f8a362260fb7,
  abstract     = {The objective of this study was to evaluate the current utilization, the level of endorsement by professional societies, and health technology assessment bodies, as well as the reimbursement levels for bariatric surgery in European countries. We performed an analysis of the indications for bariatric surgery based on national clinical and commissioning guidelines, current utilization of surgery, characteristics of patients who underwent surgery, and reimbursement tariffs in Belgium, Denmark, England, France, Germany, Italy, and Sweden. Data were obtained from national patient registries, administrative databases, and published literature for the year 2012. Despite clear consensus outlined in clinical guidelines, significant differences were found in the eligibility criteria for surgery. Patients with no significant comorbidities were deemed eligible if they had a body mass index (BMI) of 40 or 50 kg/m(2) in Denmark. Irrespective of the country, patients with comorbidities were eligible if they had a BMI of 35 kg/m(2). The highest utilization of bariatric surgery (number of surgeries per 1 M population) was observed in Belgium (928), Sweden (761), and France (571) while Italy (128), England (117), and Germany (72) had the lowest utilization. There was a strong negative correlation between utilization and average BMI level of the patient population (r = -.909, p = 0.005). The annual per capita spending on surgery differed significantly between countries, ranging from a,not sign0.54 in Germany to a,not sign4.33 in Belgium. There are significant variations in the clinical indications, utilization, and funding of bariatric surgery in European countries.},
  author       = {Borisenko, Oleg and Colpan, Zeynep and Dillemans, Bruno and Funch-Jensen, Peter and Hedenbro, Jan and Ahmed, Ahmed R.},
  issn         = {1708-0428},
  keyword      = {Bariatric surgery,Clinical indication,Reimbursement,Utilization,Health care policy},
  language     = {eng},
  number       = {8},
  pages        = {1408--1416},
  publisher    = {Springer},
  series       = {Obesity Surgery},
  title        = {Clinical Indications, Utilization, and Funding of Bariatric Surgery in Europe},
  url          = {http://dx.doi.org/10.1007/s11695-014-1537-y},
  volume       = {25},
  year         = {2015},
}